Profil
Chad May is currently the Chief Scientific Officer at Orum Therapeutics, Inc., starting in 2026.
Formerly, Dr. May was the Chief Scientific Officer at Serotiny, Inc.
Postes actifs de Chad May
| Sociétés | Poste | Début |
|---|---|---|
| ORUM THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 05/01/2026 |
Anciens postes connus de Chad May
| Sociétés | Poste | Fin |
|---|---|---|
Serotiny, Inc.
Serotiny, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting biotechnological research | Directeur Technique/Scientifique/R&D | 01/01/2026 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Orum Therapeutics, Inc.
Orum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that engages in the research and development of pharmaceuticals for cancer and immune diseases | Health Technology |
Serotiny, Inc.
Serotiny, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting biotechnological research | Commercial Services |
















